Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04854096 |
|
Recruitment Status :
Recruiting
First Posted : April 22, 2021
Last Update Posted : May 16, 2024
|
Sponsor:
NS Pharma, Inc.
Collaborator:
Nippon Shinyaku Co., Ltd.
Information provided by (Responsible Party):
NS Pharma, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 24, 2024 |
| Estimated Study Completion Date : | May 24, 2024 |